hiv therapy combination broadly neutralizing antibodies humanized mice 
human antibodies human immunodeficiency virus- hiv- can neutralize broad range viral isolates vitro protect non-human primates infection12 previous work showed antibodies exert selective pressure virus escape variants emerge within short period time34 however experiments performed recent discovery potent anti-hiv- antibodies improvement structure-based design5- re-examine passive antibody transfer therapeutic modality hiv--infected humanized mice although hiv- can escape antibody monotherapy combinations broadly neutralizing antibodies can effectively control hiv- infection suppress viral load levels detection moreover contrast antiretroviral therapy10- longer half-life antibodies led control viraemia average days cessation therapy thus combinations potent monoclonal antibodies can effectively control hiv- replication humanized mice re-examined therapeutic modality hiv--infected individuals 
